The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia
- PMID: 22382894
- PMCID: PMC3565839
- DOI: 10.1038/leu.2012.34
The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Caligiuri MA, Strout MP, Lawrence D, Arthur DC, Baer MR, Yu F, et al. Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res. 1998;58:55–59. - PubMed
-
- Schnittger S, Kinkelin U, Schoch C, Heinecke A, Haase D, Haferlach T, et al. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia. 2000;14:796–804. - PubMed
-
- Döhner K, Tobis K, Ulrich R, Fröhling S, Benner A, Schlenk RF, et al. Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. J Clin Oncol. 2002;20:3254–3261. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- CA089341/CA/NCI NIH HHS/United States
- U10 CA033601/CA/NCI NIH HHS/United States
- U24 CA114725/CA/NCI NIH HHS/United States
- U10 CA101140/CA/NCI NIH HHS/United States
- P30 CA016058/CA/NCI NIH HHS/United States
- CA77658/CA/NCI NIH HHS/United States
- CA31946/CA/NCI NIH HHS/United States
- CA140158/CA/NCI NIH HHS/United States
- CA33601/CA/NCI NIH HHS/United States
- P50 CA140158/CA/NCI NIH HHS/United States
- CA16058/CA/NCI NIH HHS/United States
- CA101140/CA/NCI NIH HHS/United States
- U10 CA077658/CA/NCI NIH HHS/United States
- U10 CA031946/CA/NCI NIH HHS/United States
- R21 CA129657/CA/NCI NIH HHS/United States
- R01 CA089341/CA/NCI NIH HHS/United States
- CA129657/CA/NCI NIH HHS/United States
- CA114725/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
